Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Cerus Corp. | 4 | 0 | 1 | 0 | €1.71 | €3.26 | 90.538% |
| Centene Corp. | 15 | 0 | 2 | 0 | €71.62 | €82.57 | 15.290% |
| Celldex Therapeutics | 11 | 1 | 2 | 0 | €34.80 | €56.62 | 62.693% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €15.23 | €24.13 | 58.458% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €50.63 | €55.00 | 8.631% |
| Cara Therapeutics Inc. | 10 | 1 | 2 | 0 | €0.70 | €4.62 | 563.503% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Bruker Corp. | 8 | 1 | 1 | 0 | €70.40 | €84.02 | 19.352% |
| Brookdale Sr Lvg | 2 | 0 | 0 | 0 | €6.25 | €8.27 | 32.365% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.57 | - | - |
| Boston Scientific | 47 | 0 | 10 | 0 | €70.00 | €73.22 | 4.604% |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €94.52 | - | - |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €76.50 | €75.94 | -0.737% |
| Bio-Rad Labs Inc. A | 7 | 0 | 1 | 0 | €266.80 | €445.58 | 67.010% |
| Biolife Solutions Inc | 1 | 0 | 1 | 0 | €19.50 | - | - |
| Biogen Inc. | 47 | 1 | 7 | 1 | €210.70 | €294.45 | 39.748% |
| Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €6.00 | €11.05 | 84.120% |
| BeiGene Ltd ADR | 9 | 1 | 2 | 0 | €160.00 | €241.54 | 50.965% |
| Bayer AG | 15 | 1 | 1 | 0 | €28.08 | €50.00 | 78.063% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €72.14 | €100.00 | 38.619% |
| Axonics Modulation Technologies Inc | 9 | 0 | 0 | 0 | €58.50 | €66.53 | 13.724% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €8.25 | €10.00 | 21.212% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Atossa Genetics Inc | 7 | 1 | 2 | 0 | €1.50 | €3.74 | 149.640% |